Afuco™ Anti-Human LCAT ADCC Therapeutic Antibody, ADCC Enhanced
Anti-LCAT ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-LCAT antibodies are used for treating atherosclerosis, coronary heart disease, thrombosis, and for decreasing or prevention of accumulation of cholesterol in a subject by modifying LCAT polypeptide.
Supplier | Creative Biolabs |
---|---|
Product # | AFC-465CL |
Pricing | Inquiry |
Host | Human |
Target | LCAT |
Species Reactivity | Human |
Type | ADCC enhanced antibody |
Storage | Store at -20°C for long-term storage. Store at 4°C for up to one month. Avoid freeze/thaw cycles. |